Blog

  • A New Generation of Technologies Can Help Transform Healthcare

    Note: this post was originally published as a guest column on 'Building a Smarter Planet' on November 14, 2013   I’ve spent much of my life surrounded by doctors. Literally. Both of my parents are physicians. One of my sisters is a doctor; the other is studying to become one. So it’s no wonder that I was bitten by the medical bug. I, however, gravitated toward the business and company-building side of healthcare, where I have spent my entire career. Today, I…

  • Bullish on Boston: Why Biotech (and More) is Booming

    I spend a lot of time in Boston these days. So do many of my partners. In fact, half of our partnership serves on boards in Boston, and we have about two dozen Boston companies in our active portfolio. This is not a new phenomenon—NEA has always been among the most active VCs in Boston—but today we’re spending more time here than ever before. Why? Because we’re seeing more opportunity here than ever before. This might sound counterintuitive at a time when many in our…

  • Topera Medical: The Legend of Sanjiv Narayan

    Ron Burgundy: “What cologne you gonna go with? London Gentleman? Or wait…No, no, no. Hold on. Blackbeard's Delight!” Brian Fantana: “No... It's called Sex Panther by Odeon…They've done studies, you know.  Sixty percent of the time, it works every time." Ron Burgundy: "That doesn't make sense..." —    From Anchorman: The Legend of Ron Burgundy Atrial fibrillation (AF) is a difficult disease for patients and an…

  • Managing personal health through social, mobile technologies: it’s not an app, it’s an ecosystem.

    Today Welltok®, developers of the CaféWell® social health management platform that enables consumers to optimize their health in partnership with plans and providers, announced a Series B round of funding to accelerate product development and increase focus on strategic partnerships. NEA believes that Welltok is uniquely positioned to deliver a vital service to consumers and we are thrilled to be a new investor in an already strong syndicate—particularly with the…

  • Capital Crunch:  Life Sciences Startups Look to New Sources of Funding

    It’s no secret that the flow of capital into the life sciences industry has slowed to a trickle over the last several years. The number of funds being raised continues to decline, with only a handful of firms raising fresh funds in the past two years (including NEA), leaving venture capitalists with a shortage of dry powder and an ever-dwindling appetite for risk. In 2012, the sector saw a 10 percent drop in total dollars invested and a six percent decrease in the number of deals.…